BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31318234)

  • 1. The development of a short form of the DePaul Symptom Questionnaire.
    Sunnquist M; Lazarus S; Jason LA
    Rehabil Psychol; 2019 Nov; 64(4):453-462. PubMed ID: 31318234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany.
    Froehlich L; Hattesohl DBR; Jason LA; Scheibenbogen C; Behrends U; Thoma M
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34201825
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychometric evaluation of the DePaul Symptom Questionnaire-Short Form (DSQ-SF) among adults with Long COVID, ME/CFS, and healthy controls: A machine learning approach.
    McGarrigle WJ; Furst J; Jason LA
    J Health Psychol; 2024 Jan; ():13591053231223882. PubMed ID: 38282368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health outcomes of sensory hypersensitivities in myalgic encephalomyelitis/chronic fatigue syndrome and multiple sclerosis.
    Maeda KI; Islam MF; Conroy KE; Jason L
    Psychol Health Med; 2023 Dec; 28(10):3052-3063. PubMed ID: 36977713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
    Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DePaul Symptom Questionnaire-2: A Validation Study.
    Bedree H; Sunnquist M; Jason LA
    Fatigue; 2019; 7(3):166-179. PubMed ID: 32685281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test-Retest Reliability of the DePaul Symptom Questionnaire.
    Jason LA; So S; Brown AA; Sunnquist M; Evans M
    Fatigue; 2015 Jan; 3(1):16-32. PubMed ID: 26973799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the PROMIS
    Yang M; Keller S; Lin JS
    Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
    Rekeland IG; Sørland K; Bruland O; Risa K; Alme K; Dahl O; Tronstad KJ; Mella O; Fluge Ø
    PLoS One; 2022; 17(9):e0274472. PubMed ID: 36121803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Development of the DePaul Symptom Questionnaire: Original, Expanded, Brief, and Pediatric Versions.
    Jason LA; Sunnquist M
    Front Pediatr; 2018; 6():330. PubMed ID: 30460215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are current chronic fatigue syndrome criteria diagnosing different disease phenotypes?
    Maclachlan L; Watson S; Gallagher P; Finkelmeyer A; Jason LA; Sunnquist M; Newton JL
    PLoS One; 2017; 12(10):e0186885. PubMed ID: 29053742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom-based clusters in people with ME/CFS: an illustration of clinical variety in a cross-sectional cohort.
    Vaes AW; Van Herck M; Deng Q; Delbressine JM; Jason LA; Spruit MA
    J Transl Med; 2023 Feb; 21(1):112. PubMed ID: 36765375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain is associated with reduced quality of life and functional status in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Strand EB; Mengshoel AM; Sandvik L; Helland IB; Abraham S; Nes LS
    Scand J Pain; 2019 Jan; 19(1):61-72. PubMed ID: 30325738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Brief Questionnaire to Assess Post-Exertional Malaise.
    Cotler J; Holtzman C; Dudun C; Jason LA
    Diagnostics (Basel); 2018 Sep; 8(3):. PubMed ID: 30208578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating Multiple Sclerosis from Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.
    Jason LA; Ohanian D; Brown A; Sunnquist M; McManimen S; Klebek L; Fox P; Sorenson M
    Insights Biomed; 2017; 2(2):. PubMed ID: 29430570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical autonomic network connectivity predicts symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Zinn MA; Jason LA
    Int J Psychophysiol; 2021 Dec; 170():89-101. PubMed ID: 34662673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
    Strassheim VJ; Sunnquist M; Jason LA; Newton JL
    BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating Post-Polio Syndrome from Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.
    Klebek L; Sunnquist M; Jason LA
    Fatigue; 2019; 7(4):196-206. PubMed ID: 33014628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthostatic intolerance and neurocognitive impairment in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Gaglio CL; Islam MF; Cotler J; Jason LA
    Epidemiol Methods; 2022 Jan; 11(1):20210033. PubMed ID: 36310761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.
    Billing-Ross P; Germain A; Ye K; Keinan A; Gu Z; Hanson MR
    J Transl Med; 2016 Jan; 14():19. PubMed ID: 26791940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.